98Y-12252-59233
3 vaccinations
7 coded responses
40 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-04-16
Registered in v-safe
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Health check-in — day 0, dose 1Feeling: Fair · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-19
-
2021-04-20
Survey response — days 1–6 daily, dose 1MedDRA: Dry skin — Feeling: GoodFree text: My skin has been extra dry on my face and neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — days 1–6 daily, dose 1MedDRA: Dry skin — Feeling: GoodFree text: The skin on my face is very dry, more than is normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — days 1–6 daily, dose 1MedDRA: Dry skin — Feeling: GoodFree text: Facial skin is dryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-04-30
- 2021-05-07
-
2021-05-11
Dose 2 — Pfizer-BioNTech
-
2021-05-11
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-22
-
2021-08-10
Survey response — 3 months, dose 2MedDRA: Nasal dryness — Feeling: GoodFree text: I continue to have extreme dryness right at the upper entrance of my nostrils, inside on both sides. Lotion doesn't provide much reliefMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-09
-
2021-11-13
Dose 3 — Pfizer-BioNTech
-
2021-11-13
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-15
Survey response — days 1–6 daily, dose 3MedDRA: Disturbance in attention — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessFree text: Can't focusMedDRA releases: 2024-11 · check-in free text available
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
-
2021-11-27
Survey response — day 14, dose 3MedDRA: Dry skin, Intermenstrual bleeding, Nasal dryness — Feeling: GoodFree text: 1 - Breakthrough menstrual bleeding, off cycle from my birth control cycle 2- Extreme skin dryness at the edge of my nostrils, just inside the edge of the noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-04
- 2021-12-13
-
2021-12-18
Survey response — day 35, dose 3MedDRA: Rosacea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with rosacea, treating it with an Rx creamMedDRA releases: 2024-11 · check-in free text available
-
2021-12-18
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-22
- 2021-12-25
-
2021-12-27
Call successfulParticipant prefers to complete VAERS report online
- 2022-02-12
- 2022-05-14
- 2022-11-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-11 | Pfizer-BioNTech | |
| 3 | 2021-11-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): My skin has been extra dry on my face and neck
Systemic reaction (other): The skin on my face is very dry, more than is normal
Systemic reaction (other): Facial skin is dry
Release 9 — 3 months, dose 2
Symptoms: I continue to have extreme dryness right at the upper entrance of my nostrils, inside on both sides. Lotion doesn't provide much relief
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Can't focus
Release 10 — day 14, dose 3
Symptoms: 1 - Breakthrough menstrual bleeding, off cycle from my birth control cycle 2- Extreme skin dryness at the edge of my nostrils, just inside the edge of the nose
Release 10 — day 35, dose 3
Symptoms: Diagnosed with rosacea, treating it with an Rx cream
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dry skin | · | · | ✓ |
| SD | Intermenstrual bleeding | · | · | ✓ |
| SD | Nasal dryness | ✓ | · | ✓ |
| SD | Rosacea | · | · | ✓ |
| SRO | Disturbance in attention | · | · | ✓ |
| SRO | Dry skin | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release